| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d8c72929deb0d5e6041dd021d8ab6e90 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5047 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-12 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 |
| filingDate |
2011-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d0841a517976030d49c45668e9edd41d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e13bbc72fcabe4b3718b9494e33a1c2a |
| publicationDate |
2017-06-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2620232-T3 |
| titleOfInvention |
Alcohol-resistant oral pharmaceutical form |
| abstract |
Use of an inert filler in the coating of prolonged-release microgranules comprising from the center to the periphery: - a neutral support, - at least one mounting layer comprising at least one active ingredient and a pharmaceutically acceptable binder; and - at least one extended-release coating layer comprising a hydrophobic coating polymer selected from the non-water-soluble cellulose derivatives to confer on said microgranules an alcohol resistance, characterized in that the amount of inert filler in the coating prolonged-release form of the microgranules is at least 20% talc with respect to the dry weight of the hydrophobic coating polymer, and characterized in that said microgranules are contained in a prolonged-release oral pharmaceutical form of at least one active ingredient of single daily administration. |
| priorityDate |
2010-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |